Cancer Letters
Volume 203, Issue 2 , Pages 145-154 , January 2004

TNF-α-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines

  • Dharam P. Chopra

      Affiliations

    • Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48201, USA
    • Corresponding Author InformationCorresponding author. Address: Institute of Environmental Health Sciences, Wayne State University, 2727 Second Avenue, Room 4000, Detroit, MI 48201, USA. Tel.: +1-313-961-2816; fax: +1-313-577-0082
    • ,
  • Raymond E. Menard

      Affiliations

    • Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA
    • ,
  • Jakub Januszewski

      Affiliations

    • Institute of Environmental Health Sciences, Wayne State University, Detroit, MI 48201, USA
    • Present address: 1200 Academy Street, Hicks Center Box 375, Kalamazoo, MI 49006, USA.
    • ,
  • Raymond R. Mattingly

      Affiliations

    • Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA

Received 27 June 2003 ,Revised 23 September 2003 ,Accepted 24 September 2003.

References 

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, CA. Cancer J. Clin. 1999;49:8–31
  2. Coffey DS. Prostate cancer. An overview of an increasing dilemma. Cancer. 1993;71:880–886
  3. Helson L, Helson C, Green S. Effects of murine tumor necrosis factor on heterotransplanted human tumors. Exp. Cell. Biol. 1979;47:53–60
  4. Niitsu Y, Watanabe N, Umeno H, Sone H, Neda H, Yamauchi N, et al.  Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis. Cancer Res. 1988;48:654–657
  5. Watanabe N, Niitsu Y, Umeno H, Sone H, Neda H, Yamauchi N, et al.  Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Res. 1988;48:650–653
  6. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 1985;230:943–945
  7. Watanabe N, Niitsu Y, Neda H, Sone H, Yamauchi N, Umetsu T, et al. Antitumor effect of tumor necrosis factor against various primarily cultured human cancer cells. Jpn. J. Cancer Res. 1985;76:1115–1119
  8. Nakajima Y, DelliPizzi A, Mallouh C, Ferreri NR. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines. Urol. Res. 1995;23:205–210
  9. Kim JY, Lee S, Hwangbo B, Lee CT, Kim YW, Han SK, et al.  NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis. Biochem. Biophys. Res. Commun. 2000;273:140–146
  10. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996;84:299–306
  11. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, et al.  FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death—inducing signaling complex. Cell. 1996;85:817–827
  12. Boldin MP, Goncharov TM, Goltsev Y, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell. 1996;85:803–815
  13. Beg AA, Baltimore D. An essential role for NF-kappa-B in preventing TNF-alpha-induced cell death. Science. 1996;274:782–784
  14. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 1996;274:787–789
  15. Rivera-Walsh I, Cvijic ME, Xiao G, Sun SC. The NF-kappa B signaling pathway is not required for Fas ligand gene induction but mediates protection from activation-induced cell death. J. Biol. Chem. 2000;275:5222–5230
  16. Bonizzi G, Piette J, Merville MP, Bours VJ. Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. Immunology. 1997;159:5264–5272
  17. Romano MF, Lamberti A, Turco MC, Venuta S. CD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-kappaB/Rel transcription factors on chemotherapy-induced apoptosis. Leuk. Lymphoma. 2000;36:255–262
  18. Delhase M, Hayakawa M, Chen Y, Karin M. Positive and negative regulation of Ikappa-B kinase activity through IKKbeta subunit phosphorylation. Science. 1999;284:309–313
  19. Chopra DP, Grignon DJ, Joiakim A, Mathieu PA, Mohamed A, Sakr WA, et al.  Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma. J. Cell. Physiol. 1996;169:269–280
  20. Chopra DP, Sarkar FH, Grignon DJ, Sakr WA, Mohamed A, Waghray A. Growth of human nondiploid primary prostate tumor epithelial cells in vitro. Cancer Res. 1997;57:3688–3692
  21. Joiakim AP, Chopra DP. Retinoic acid and calcium regulation of p53, transforming growth factor-beta 1, and transforming growth factor-alpha gene expression and growth in adenovirus 12-SV40-transformed human tracheal gland epithelial cells. Am. J. Respir. Cell Mol. Biol. 1993;4:408–416
  22. DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh H, et al. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 1996;4:1295–1304
  23. De Bosscher K, Schimtz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA. 1997;94:13504–13509
  24. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol. 2000;60:1051–1059
  25. Kampf C, Relova AJ, Sandler S, Roomans GM. Effects of TNF-alpha, IFN-gamma and IL-beta on normal human bronchial epithelial cells. Eur. Respir. J. 1999;14:84–91
  26. Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch. Biochem. Biophys. 2000;376:338–346
  27. Nakajima Y, DelliPizzi AM, Mallouh C, Ferreri NR. TNF-mediated cytotoxicity and resistance in human prostate cancer cell lines. Prostate. 1996;29:296–302
  28. Yu R, Mandlekar S, Ruben S, Ni J, Kong AN. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Cancer Res. 2000;60:2384–2389
  29. Sumitomo M, Tachibana M, Nakashima J, Murai M, Miyajima A, Kimura F, et al.  An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J. Urol. 1999;161:674–679
  30. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, et al.  Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res. 1997;57:1758–1768
  31. Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G, et al. Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl. Acad. Sci. USA. 1998;95:13664–13669
  32. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 1998;279:1954–1958

PII: S0304-3835(03)00658-X

doi: 10.1016/j.canlet.2003.09.016

Cancer Letters
Volume 203, Issue 2 , Pages 145-154 , January 2004

Article Tools

* Image Usage & Resolution